Sanjay Lakhotia
Corporate Officer/Principal bei ZENITH CAPITAL CORP.
Vermögen: 7 298 $ am 31.03.2024
Ursprung des Netzwerks ersten Grades von Sanjay Lakhotia
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Sanjay Lakhotia
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
ROCHE HOLDING AG | Pharmaceuticals: Major | Sales & Marketing | |
APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
RESVERLOGIX CORP. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO Chief Executive Officer Founder Chairman Director/Board Member Corporate Officer/Principal | |
Molecular Medicine BioServices, Inc.
Molecular Medicine BioServices, Inc. Pharmaceuticals: MajorHealth Technology Molecular Medicine BioServices, Inc. is a company that provides services in the pharmaceutical industry. The company is based in Carlsbad, CA. The company has signed a manufacturing agreement with Cardium Therapeutics for the production of Generx and have expanded their services to better serve client vaccine development and testing needs. The company was acquired by Sigma-Aldrich Corp., part of Merck KGaA on November 19, 2015. | Pharmaceuticals: Major | Sales & Marketing | |
NGN Capital LLC
NGN Capital LLC Investment ManagersFinance NGN Capital LLC (NGN Capital) is a venture capital firm founded in 2003 by Kenneth S. Abramowitz and William J. Gedale. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Vivaldi Biosciences, Inc.
Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO. | Drugstore Chains | Director/Board Member | |
Reviva Pharmaceuticals, Inc.
Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reviva Pharmaceuticals, Inc. operates as a clinical stage development pharmaceutical company. The firm develops various therapies using chemical genomics for treatment of central nervous system, cardiovascular, metabolic and inflammatory diseases. The company was founded by Laxminarayan Bhat in 2006 and is headquartered in Cupertino, CA. | Pharmaceuticals: Major | Director/Board Member | |
SYNCONA LIMITED | Investment Trusts/Mutual Funds | Director/Board Member | |
Stanford University | College/University | Doctorate Degree | |
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
University of Manitoba | College/University | Graduate Degree | |
Technische Universität München | College/University | Doctorate Degree | |
University of Calgary | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Technical University of Denmark | College/University | Graduate Degree | |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Lund | College/University | Doctorate Degree | |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member | |
Institute of Chartered Accountants of Alberta | Corporate Officer/Principal | ||
IMRIS INC. | Medical Specialties | Director of Finance/CFO | |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Investment Managers | Private Equity Investor | |
Haworth Ltd.
Haworth Ltd. Office Equipment/SuppliesProducer Manufacturing Haworth Ltd. manufactures institutional furniture. The company was founded in 1977 and is headquartered in Toronto, Canada. | Office Equipment/Supplies | Corporate Officer/Principal | |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Medical/Nursing Services | Director/Board Member | |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Miscellaneous Commercial Services | Chief Executive Officer | |
Cellastra, Inc.
Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Biotechnology | Chairman | |
QUE Oncology, Inc.
QUE Oncology, Inc. Pharmaceuticals: MajorHealth Technology QUE Oncology, Inc. engages in preventing and treating life-threatening cancers such as prostate cancer, breast cancer, melanoma, and cancer pain; and related conditions. The company is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Chief Executive Officer | |
RTDS Technologies, Inc.
RTDS Technologies, Inc. Information Technology ServicesTechnology Services Part of AMETEK, Inc., RTDS Technologies, Inc. is a Canadian company that specializes in hardware-in-the-loop testing of protection and control equipment. The company is based in Winnipeg, Canada. The company's flagship product, the RTDS Simulator, is the world standard for real-time simulation in the power industry. The company is leaders in their field and are driving innovation in simulating the grid of tomorrow. The company's technology allows for the validation of novel technologies and improves operator confidence. RTDS Technologies was founded in 1989 and has been instrumental in changing the power industry with their introduction of the world's first fully digital real-time power system simulator. Neil Mackenzie, Trevor Maguire, Rudi Wierckx, James Giesbrecht, and Rick Kuffel founded the company in 1994, and Kelly McNeill has been the CEO since 2014. RTDS Technologies was acquired by AMETEK, Inc. on November 01, 2022 for $238.26 million. | Information Technology Services | Chief Executive Officer | |
Revitope Oncology, Inc.
Revitope Oncology, Inc. Hospital/Nursing ManagementHealth Services Revitope Oncology, Inc. develops a programmable antibody circuit pipeline in particular redirecting T cells to tumors. The company was founded by Andrew Allen and Mark Cobbold and is headquartered in Cambridge, MA. | Hospital/Nursing Management | Chief Executive Officer | |
Kickshaw Ventures Ltd.
Kickshaw Ventures Ltd. Financial ConglomeratesFinance Kickshaw Ventures Ltd. operates as a Canadian investment company. The private company is based in Calgary, Canada. Bradley George Thompson has been the CEO of the company since 2016. | Financial Conglomerates | Chief Executive Officer | |
Kisoji Biotechnology, Inc.
Kisoji Biotechnology, Inc. BiotechnologyHealth Technology Kisoji Biotechnology, Inc. operates as a biotechnology company which develops cancer therapeutics through antibodies and stem cells. The company was founded by David S. Young and is headquartered in Montreal, Canada. | Biotechnology | Director/Board Member | |
VAXART, INC. | Biotechnology | Director/Board Member | |
Leading Biosciences, Inc.
Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Leading Biosciences, Inc. provides healthcare services. It offers therapy for severe sepsis, septic shock, and multi-organ failure. The company was founded by John Rodenrys and is headquartered in Carlsbad, CA. | Miscellaneous Commercial Services | Director/Board Member | |
TOLREMO therapeutics AG
TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services TOLREMO therapeutics AG engages in discovering and developing therapies for treating cancer patients. The firm serves on academic research laboratories, flourishing life sciences spin-offs and cutting-edge technology platforms. The company was founded by Stefanie Flückiger-Mangual, Wilhelm Krek, Karl-Heinz Altmann, Isaac Kobrin, and Emmanuel Savioz in March 2017 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Chairman | |
Actym Therapeutics, Inc.
Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actym Therapeutics, Inc. engages in development of novel immuno-oncology therapies. The company was founded by Christopher D. Thanos and Laura Hix Glickman and is headquartered in Berkeley, CA. | Pharmaceuticals: Major | Chairman | |
ELEVATION ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
ENVERIC BIOSCIENCES, INC. | Pharmaceuticals: Other | Director/Board Member | |
Wyvern Pharmaceuticals, Inc. | Chief Executive Officer | ||
Avamab Pharma, Inc. | Chief Executive Officer | ||
RAKOVINA THERAPEUTICS INC. | Financial Conglomerates | Director/Board Member | |
Sardona Therapeutics, Inc. | Director/Board Member | ||
MycRx
MycRx Miscellaneous Commercial ServicesCommercial Services MycRx is an Australian company that focuses on improving the lives of people with cancer through direct myc inhibitors. The company's main area of expertise is the science of myc inhibition as a treatment for cancer. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
Vereinigte Staaten | 22 |
Kanada | 18 |
Deutschland | 5 |
Schweiz | 4 |
Vereinigtes Königreich | 3 |
Sektoral
Health Technology | 22 |
Consumer Services | 7 |
Commercial Services | 6 |
Finance | 5 |
Producer Manufacturing | 3 |
Operativ
Director/Board Member | 63 |
Independent Dir/Board Member | 24 |
Corporate Officer/Principal | 20 |
Chairman | 16 |
Chief Executive Officer | 16 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Julie Cherrington | 32 |
Eldon Smith | 29 |
Peter Johann | 18 |
Bradley Thompson | 17 |
Kenneth Zuerblis | 12 |
Kelly McNeill | 8 |
Anthony Cann | 7 |
Henrik Hansen | 5 |
Donald McCaffrey | 4 |
Norman Wong | 3 |
- Börse
- Insiders
- Sanjay Lakhotia
- Unternehmensverbindungen